AI/ML Innovations Inc. Announces Upcoming Webinar

Rhea-AI Summary

AI/ML Innovations, a leader in AI and machine learning solutions, announces a live webinar event on July 11th at 9:00 AM PT / 12:00 PM ET. Paul Duffy, CEO, will recap the past 90 days, discuss upcoming 90 days, and outline key Q3 milestones. The company focuses on AI and ML investments in digital health and well-being, with significant stakes in Health Gauge, Tech2Heal, and AI Rx Inc. Shares are traded under CSE: AIML, OTCQB: AIMLF, and FWB: 42FB.

Positive

• AI/ML Innovations scheduled a webinar to provide a detailed update on past and upcoming activities.
• Significant ownership in promising companies: Health Gauge (95.2%), Tech2Heal (up to 22%), and AI Rx Inc. (70%).

Negative

• None.

VICTORIA, BC / ACCESSWIRE / July 9, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading innovator in Artificial Intelligence and Machine Learning solutions, is pleased to announce an upcoming live webinar event. The webinar is scheduled for July 11^th at 9:00 AM PT / 12:00 PM ET and will be broadcast online.

This event will feature Paul Duffy, Chief Executive Officer of AI/ML Innovations Inc., who will provide a comprehensive recap of the past 90 days, an overview of the upcoming 90 days, and outline key Q3 milestones.

We invite all shareholders and interested parties to join us for this informative session.

Register here for our live event: AI/ML Innovations Inc. Q2 Recap, Next 90, and Q3 Milestones

For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com.

For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.

About AI/ML Innovations Inc. https://aiml-innovations.com/
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: AI/ML Innovations, Inc.

View the original press release on accesswire.com

FAQ

What is the date and time of the AI/ML Innovations webinar?

The AI/ML Innovations webinar is scheduled for July 11th at 9:00 AM PT / 12:00 PM ET.

Who will be presenting at the AI/ML Innovations webinar?

Paul Duffy, the CEO of AI/ML Innovations, will be presenting at the webinar.

What topics will be covered in the AI/ML Innovations webinar?

The webinar will cover a recap of the past 90 days, a preview of the next 90 days, and key Q3 milestones.

What is the stock symbol for AI/ML Innovations?

AI/ML Innovations trades under the stock symbols CSE: AIML, OTCQB: AIMLF, and FWB: 42FB.

How can I register for the AI/ML Innovations webinar?

You can register for the AI/ML Innovations webinar via the link provided in their press release.